AbCellera Announces $28M Upfront Vertex Collaboration On Multispecific T-Cell Engagers For Autoimmune Diseases, Eligible For Milestone Payments And Tiered Royalties

Benzinga Newsdesk www.benzinga.com Positive 79.8%

Neg 0% Neu 0% Pos 79.8%

Comments

No comments yet. Be the first!